2975例结核病住院患者的药品费用分析

目的 从结核病临床治疗与费用控制的角度，系统分析长沙市某医院2005年所有结核病住院患者住院费用结构中药品费用的情况，并基于结核病临床治疗的证据和实际资源利用情况，提出结核病临床治疗与费用控制的有关措施，为改善结核病临床治疗的效果与降低住院医疗费用提供科学的决策依据。方法 基于该院2005年2975例结核病住院患者的住院医疗费用方面的数据，并建立数据库，采用SPSS11．0统计分析软件对住院患者的住院医疗费用构成，从结核病的类型、支付方式和治疗结果等方面进行统计分析，并对住院患者药品费用占总住院费用的比例等情况进行系统分析。结果 结核病住院患者人均药品费用为3966．71元，药品费用所占住院总费用的比例为48．29％。结论 药品费用是构成结核病住院患者的住院医疗费用的主要费用成份，要控制结核病患者的住院医疗费用，降低药品比例是关键。

Pharmaceutical Cost Study on 2975 Tuberculosis Inpatients

Objective To systematically review the pharmaceutical cost status in hospitalization cost structure in all tuberculosis inpatients discharged in 2005 in one hospital of Changsha city in the context of tuberculosis treatment and cost control, and to present the measures to treat tuberculosis and control cost on the basis of the clinical evidence of tuberculosis therapy and actual resource utilization condition, and thus to provide the decision basis for improving the clinical effectiveness of tuberculosis and reducing the hospitalization cost. Methods The database was established on the basis of the data from hospitalization costs of 2975 tuberculosis inpatients in the hospital in 2005, the hospitalization cost structures of them were statistically analyzed in terms of tuberculosis type, payment mode and efficacy using SPSS11.0 statistical software package and the proportion of pharmaceutical cost among inpatients to hospitalization cost was systematically reviewed. Results The average pharmaceutical cost per tuberculosis inpatient was 3966. 71 yuan, and the proportion of pharmaceutical cost to total hospitalization cost 48.29%. Conclusion Pharmaceutical cost is the major cost element of the hospitalization cost among tuberculosis inpatients, and reducing the drug cost proportion is the key to control the hospitalization cost of tuberculosis inpatients.